Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07652437 · ClinicalTrials.gov registry record · NA

Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis

A NA study, sponsored by Massachusetts Institute of Technology.

Recruiting
Registry status
NA
Development phase
9
Enrollment target

NCT07652437 is a NA study that is actively recruiting participants, run by Massachusetts Institute of Technology. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07652437, a NA study, is actively recruiting participants, sponsored by Massachusetts Institute of Technology.

RECRUITING
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Knee osteoarthritis (OA) affects an estimated 654 million people over age 40 world-wide. In the United States, approximately 16% of adults over the age of 40 have knee OA. Pain, activity limitations and disability are common symptoms. Exercise is widely recommended as a non-invasive, first line strategy for people with knee OA. Yet, less than 1/3 of adults with knee OA meet recommended levels of physical activity, and rates are even lower among people who are overweight. Furthermore, adherence to evidence-based structured programs is poor once the therapeutic support is removed. End stage disease is treated by total joint replacement. Under-active people with knee OA would benefit from general walking activity, even if joint replacement surgery is expected; however, walking is difficult and motivation is low. Thus, people with knee OA encounter a difficult paradox: exercise could help decrease pain and improve function but doing so can be difficult and may not always be possible. There is a tremendous need to address this situation. This is a small device-feasibility study evaluating the Dephy ExoBoot, a wearable powered exoskeleton, in individuals with knee OA. The study assesses whether the device can reliably deliver positive assistance during walking and is tolerated across walking tasks. Additional measures, including changes in knee loading and walking speed with versus without the device, are also collected.

Interventions

  • DEVICE Dephy Exoboot

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2025-12-15
Est. Completion 2029-07-01
Phase NA

What the Registry Record Tells You About NCT07652437

The ClinicalTrials.gov registry entry for NCT07652437 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dephy Exoboot is the first listed.

NCT07652437 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07652437 about?

NCT07652437 is a clinical study titled "Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis". Knee osteoarthritis (OA) affects an estimated 654 million people over age 40 world-wide. In the United States, approximately 16% of adults over the age of 40 have knee OA. Pain, activity limitations and disability are common symptoms. Exercise is widely recommended as a non-invasive, first line stra...

What is the current status of trial NCT07652437?

This trial is currently recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2025-12-15. Estimated completion is 2029-07-01.

What interventions are being tested in trial NCT07652437?

The interventions under investigation include: Dephy Exoboot (DEVICE).

Who is sponsoring clinical trial NCT07652437?

This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.